The crystal structure of human soluble CD14 reveals a bent solenoid with a hydrophobic amino-terminal pocket

Journal of Immunology

Volumn 190, Issue 3, 2013, Pages 1304-1311

  Kelley, Stacy L ^a   Lukk, Tiit ^a   Nair, Satish K ^a   Tapping, Richard I ^a,b  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^b UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; LEUCINE; LIPOPOLYSACCHARIDE;

ACYLATION; AMINO TERMINAL SEQUENCE; ANTIGEN STRUCTURE; ARTICLE; BINDING SITE; CELL ACTIVATION; CRYSTAL STRUCTURE; HUMAN; HUMAN CELL; NUCLEOTIDE REPEAT; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FOLDING; PROTEIN STRUCTURE; SPECIES DIFFERENCE; X RAY DIFFRACTION;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, CD14; CRYSTALLOGRAPHY, X-RAY; HUMANS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; LIPOPOLYSACCHARIDES; MICE; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN STRUCTURE, TERTIARY; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY, AMINO ACID; SPECIES SPECIFICITY; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84872695651     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1202446     Document Type: Article

References (96)

1. Bazil, V., V. Horejsi, I. Hilgert, and M. J. McMichael, eds. 1982. Leucocyte typing III. White cell differentiation antigens. In The Workshop: Myeloid Panel Antibodies Recognizing the 53-kDa Molecular Weight Monocyte Antigen (CD14). Oxford University Press, Oxford, UK, p. 611-613.
2. Haziot, A., S. Chen, E. Ferrero, M. G. Low, R. Silber, and S. M. Goyert. 1988. The monocyte differentiation antigen, CD14, is anchored to the cell membrane by a phosphatidylinositol linkage. J. Immunol. 141: 547-552.
3. Simmons, D. L., S. Tan, D. G. Tenen, A. Nicholson-Weller, and B. Seed. 1989. Monocyte antigen CD14 is a phospholipid anchored membrane protein. Blood 73: 284-289. (Pubitemid 19040989)
4. Wright, S. D., R. A. Ramos, P. S. Tobias, R. J. Ulevitch, and J. C. Mathison. 1990. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 249: 1431-1433.
5. Tapping, R. I., and P. S. Tobias. 2000. Soluble CD14-mediated cellular responses to lipopolysaccharide. Chem. Immunol. 74: 108-121.
6. Salomao, R., M. K. Brunialti, M. M. Rapozo, G. L. Baggio-Zappia, C. Galanos, and M. Freudenberg. 2012. Bacterial sensing, cell signaling, and modulation of the immune response during sepsis. Shock 38: 227-242.
7. Opal, S. M., and J. Cohen. 1999. Clinical gram-positive sepsis: Does it fundamentally differ from gram-negative bacterial sepsis? Crit. Care Med. 27: 1608-1616. (Pubitemid 29406956)
8. Haziot, A., E. Ferrero, F. Kontgen, N. Hijiya, S. Yamamoto, J. Silver C. L. Stewart, and S. M. Goyert. 1996. Resistance to endotoxin shock and reduced dissemination of gram-negative bacteria in CD14-deficient mice. Immunity 4: 407-414. (Pubitemid 26174055)
9. Rietschel, E. T., H. Brade, L. Brade, W. Kaca, K. Kawahara, B. Lindner, T. Luderitz, T. Tomita, U. Schade, U. Seydel, et al. 1985. Newer aspects of the chemical structure and biological activity of bacterial endotoxins. Prog. Clin. Biol. Res. 189: 31-51.
10. Raetz, C. R., and C. Whitfield. 2002. Lipopolysaccharide endotoxins. Annu. Rev. Biochem. 71: 635-700. (Pubitemid 34800232)
11. Erridge, C., E. Bennett-Guerrero, and I. R. Poxton. 2002. Structure and function of lipopolysaccharides. Microbes Infect. 4: 837-851. (Pubitemid 35247447)
12. Hailman, E., H. S. Lichenstein, M. M. Wurfel, D. S. Miller, D. A. Johnson, M. Kelley, L. A. Busse, M. M. Zukowski, and S. D. Wright. 1994. Lipopolysaccharide (LPS)-binding protein accelerates the binding of LPS to CD14. J. Exp. Med. 179: 269-277. (Pubitemid 24012992)
13. Tobias, P. S., K. Soldau, J. A. Gegner, D. Mintz, and R. J. Ulevitch. 1995. Lipopolysaccharide binding protein-mediated complexation of lipopolysaccharide with soluble CD14. J. Biol. Chem. 270: 10482-10488.
14. Tobias, P. S., K. Soldau, and R. J. Ulevitch. 1986. Isolation of a lipopolysaccharide-binding acute phase reactant from rabbit serum. J. Exp. Med. 164: 777-793. (Pubitemid 16024834)
15. Schumann, R. R., S. R. Leong, G. W. Flaggs, P. W. Gray, S. D. Wright, J. C. Mathison, P. S. Tobias, and R. J. Ulevitch. 1990. Structure and function of lipopolysaccharide binding protein. Science 249: 1429-1431. (Pubitemid 120034117)
16. Yu, B., and S. D. Wright. 1996. Catalytic properties of lipopolysaccharide (LPS) binding protein. Transfer of LPS to soluble CD14. J. Biol. Chem. 271: 4100-4105.
17. Goyert, S. M., E. Ferrero, W. J. Rettig, A. K. Yenamandra, F. Obata, and M. M. Le Beau. 1988. The CD14 monocyte differentiation antigen maps to a region encoding growth factors and receptors. Science 239: 497-500. (Pubitemid 18084313)
18. Pugin, J., I. D. Heumann, A. Tomasz, V. V. Kravchenko, Y. Akamatsu, M. Nishijima, M. P. Glauser, P. S. Tobias, and R. J. Ulevitch. 1994. CD14 is a pattern recognition receptor. Immunity 1: 509-516.
19. Shimazu, R., S. Akashi, H. Ogata, Y. Nagai, K. Fukudome, K. Miyake, and M. Kimoto. 1999. MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4. J. Exp. Med. 189: 1777-1782. (Pubitemid 29272694)
20. Núnez Miguel, R., J. Wong, J. F. Westoll, H. J. Brooks, L. A. O'Neill, N. J. Gay, C. E. Bryant, and T. P. Monie. 2007. A dimer of the Toll-like receptor 4 cytoplasmic domain provides a specific scaffold for the recruitment of signalling adaptor proteins. PLoS ONE 2: E788.
21. Gioannini, T. L., A. Teghanemt, D. Zhang, N. P. Coussens, W. Dockstader, S. Ramaswamy, and J. P. Weiss. 2004. Isolation of an endotoxin-MD-2 complex that produces Toll-like receptor 4-dependent cell activation at picomolar concentrations. Proc. Natl. Acad. Sci. USA 101: 4186-4191. (Pubitemid 38405904)
22. Prohinar, P., F. Re, R. Widstrom, D. Zhang, A. Teghanemt, J. P. Weiss, and T. L. Gioannini. 2007. Specific high affinity interactions of monomeric endotoxin. protein complexes with Toll-like receptor 4 ectodomain. J. Biol. Chem. 282: 1010-1017. (Pubitemid 47076551)
23. Teghanemt, A., P. Prohinar, T. L. Gioannini, and J. P. Weiss. 2007. Transfer of monomeric endotoxin from MD-2 to CD14: Characterization and functional consequences. J. Biol. Chem. 282: 36250-36256.
24. Teghanemt, A., R. L. Widstrom, T. L. Gioannini, and J. P. Weiss. 2008. Isolation of monomeric and dimeric secreted MD-2. Endotoxin.sCD14 and Toll-like receptor 4 ectodomain selectively react with the monomeric form of secreted MD-2. J. Biol. Chem. 283: 21881-21889.
25. Jack, R. S., U. Grunwald, F. Stelter, G. Workalemahu, and C. Schutt. 1995. Both membrane-bound and soluble forms of CD14 bind to gram-negative bacteria. Eur. J. Immunol. 25: 1436-1441.
26. Grunwald, U., X. Fan, R. S. Jack, G. Workalemahu, A. Kallies, F. Stelter, and C. Schutt. 1996. Monocytes can phagocytose Gram-negative bacteria by a CD14-dependent mechanism. J. Immunol. 157: 4119-4125. (Pubitemid 126449324)
27. Fan, X., F. Stelter, R. Menzel, R. Jack, I. Spreitzer, T. Hartung, and C. Schutt. 1999. Structures in Bacillus subtilis are recognized by CD14 in a lipopolysaccharide binding protein-dependent reaction. Infect. Immun. 67: 2964-2968. (Pubitemid 29244715)
28. Stelter, F., M. Bernheiden, R. Menzel, R. S. Jack, S. Witt, X. Fan, M. Pfister, and C. Schutt. 1997. Mutation of amino acids 39-44 of human CD14 abrogates binding of lipopolysaccharide and Escherichia coli. Eur. J. Biochem. 243: 100-109. (Pubitemid 27060390)
29. Schiff, D. E., L. Kline, K. Soldau, J. D. Lee, J. Pugin, P. S. Tobias, and R. J. Ulevitch. 1997. Phagocytosis of gram-negative bacteria by a unique CD14-dependent mechanism. J. Leukoc. Biol. 62: 786-794. (Pubitemid 28015627)
30. Wurfel, M. M., and S. D. Wright. 1997. Lipopolysaccharide-binding protein and soluble CD14 transfer lipopolysaccharide to phospholipid bilayers: Preferential interaction with particular classes of lipid. J. Immunol. 158: 3925-3934. (Pubitemid 127488753)
31. Yu, B., E. Hailman, and S. D. Wright. 1997. Lipopolysaccharide binding protein and soluble CD14 catalyze exchange of phospholipids. J. Clin. Invest. 99: 315-324. (Pubitemid 27053990)
32. Wang, P. Y., R. L. Kitchens, and R. S. Munford. 1998. Phosphatidylinositides bind to plasma membrane CD14 and can prevent monocyte activation by bacterial lipopolysaccharide. J. Biol. Chem. 273: 24309-24313. (Pubitemid 28454917)
33. Nakata, T., M. Yasuda, M. Fujita, H. Kataoka, K. Kiura, H. Sano, and K. Shibata. 2006. CD14 directly binds to triacylated lipopeptides and facilitates recognition of the lipopeptides by the receptor complex of Toll-like receptors 2 and 1 without binding to the complex. Cell. Microbiol. 8: 1899-1909. (Pubitemid 44680872)
34. Dziarski, R., R. I. Tapping, and P. S. Tobias. 1998. Binding of bacterial peptidoglycan to CD14. J. Biol. Chem. 273: 8680-8690. (Pubitemid 28176145)
35. Gupta, D., T. N. Kirkland, S. Viriyakosol, and R. Dziarski. 1996. CD14 is a cellactivating receptor for bacterial peptidoglycan. J. Biol. Chem. 271: 23310-23316. (Pubitemid 26314774)
36. Savedra, R., Jr., R. L. Delude, R. R. Ingalls, M. J. Fenton, and D. T. Golenbock. 1996. Mycobacterial lipoarabinomannan recognition requires a receptor that shares components of the endotoxin signaling system. J. Immunol. 157: 2549-2554. (Pubitemid 126450468)
37. Yu, W., E. Soprana, G. Cosentino, M. Volta, H. S. Lichenstein, G. Viale, and D. Vercelli. 1998. Soluble CD14(1-152) confers responsiveness to both lipoarabinomannan and lipopolysaccharide in a novel HL-60 cell bioassay. J. Immunol. 161: 4244-4251. (Pubitemid 28469007)
38. Elass, E., B. Coddeville, Y. Guérardel, L. Kremer, E. Maes, J. Mazurier, and D. Legrand. 2007. Identification by surface plasmon resonance of the mycobacterial lipomannan and lipoarabinomannan domains involved in binding to CD14 and LPS-binding protein. FEBS Lett. 581: 1383-1390. (Pubitemid 46463956)
39. Lien, E., T. J. Sellati, A. Yoshimura, T. H. Flo, G. Rawadi, R. W. Finberg, J. D. Carroll, T. Espevik, R. R. Ingalls, J. D. Radolf, and D. T. Golenbock. 1999. Toll-like receptor 2 functions as a pattern recognition receptor for diverse bacterial products. J. Biol. Chem. 274: 33419-33425. (Pubitemid 129511647)
40. Takeuchi, O., K. Hoshino, T. Kawai, H. Sanjo, H. Takada, T. Ogawa, K. Takeda, and S. Akira. 1999. Differential roles of TLR2 and TLR4 in recognition of gramnegative and gram-positive bacterial cell wall components. Immunity 11: 443-451. (Pubitemid 29504199)
41. Pugin, J., C. C. Schurer-Maly, D. Leturcq, A. Moriarty, R. J. Ulevitch, and P. S. Tobias. 1993. Lipopolysaccharide activation of human endothelial and epithelial cells is mediated by lipopolysaccharide-binding protein and soluble CD14. Proc. Natl. Acad. Sci. USA 90: 2744-2748. (Pubitemid 23113493)
42. Tapping, R. I., and P. S. Tobias. 1997. Cellular binding of soluble CD14 requires lipopolysaccharide (LPS) and LPS-binding protein. J. Biol. Chem. 272: 23157-23164. (Pubitemid 27392446)
43. Haziot, A., G.W. Rong, V. Bazil, J. Silver, and S. M. Goyert. 1994. Recombinant soluble CD14 inhibits LPS-induced tumor necrosis factor-alpha production by cells in whole blood. J. Immunol. 152: 5868-5876. (Pubitemid 24174167)
44. Stelter, F., M. Pfister, M. Bernheiden, R. S. Jack, P. Bufler, H. Engelmann, and C. Schutt. 1996. The myeloid differentiation antigen CD14 is N-and Oglycosylated. Contribution of N-linked glycosylation to different soluble CD14 isoforms. Eur. J. Biochem. 236: 457-464.
45. Majerle, A., J. Kidric, and R. Jerala. 1999. Expression and refolding of functional fragments of the human lipopolysaccharide receptor CD14 in Escherichia coli and Pichia pastoris. Protein Expr. Purif. 17: 96-104. (Pubitemid 29504383)
46. Bai, J., J. Yin, Z. D. Wang, W. Wang, Z. Z. Wang, and W. Song. 2001. [Clone and expression of human soluble CD14 and study of its function]. Sheng Wu Gong Cheng Xue Bao. 17: 269-272.
47. Nomura, S., K. Inamori, T. Muta, S. Yamazaki, Y. Sunakawa, S. Iwanaga, and K. Takeshige. 2003. Purification and characterization of human soluble CD14 expressed in Pichia pastoris. Protein Expr. Purif. 28: 310-320. (Pubitemid 36562422)
48. Burkhardt, M., A. LopezAcosta, K. Reiter, V. Lopez, and A. Lees. 2007. Purification of soluble CD14 fusion proteins and use in an electrochemiluminescent assay for lipopolysaccharide binding. Protein Expr. Purif. 51: 96-101. (Pubitemid 44821858)
49. Meng, J., P. Parroche, D. T. Golenbock, and C. J. McKnight. 2008. The differential impact of disulfide bonds and N-linked glycosylation on the stability and function of CD14. J. Biol. Chem. 283: 3376-3384.
50. Albright, S., B. Chen, K. Holbrook, and N. U. Jain. 2008. Solution NMR studies provide structural basis for endotoxin pattern recognition by the innate immune receptor CD14. Biochem. Biophys. Res. Commun. 368: 231-237.
51. Vida, A., B. Bardoel, F. Milder, L. Majoros, A. Sumegi, A. Bácsi, G. Vereb, K. P. van Kessel, J. A. van Strijp, and P. Antal-Szalmás. 2012. Fusion of the Fc part of human IgG1 to CD14 enhances its binding to gram-negative bacteria and mediates phagocytosis by Fc receptors of neutrophils. Immunol. Lett. 146: 31-39.
52. Kim, J. I., C. J. Lee, M. S. Jin, C. H. Lee, S. G. Paik, H. Lee, and J. O. Lee. 2005. Crystal structure of CD14 and its implications for lipopolysaccharide signaling. J. Biol. Chem. 280: 11347-11351. (Pubitemid 40418442)
53. Rangel-Frausto, M. S. 2005. Sepsis: Still going strong. Arch. Med. Res. 36: 672-681. (Pubitemid 41436236)
54. Guan, Y., D. R. Ranoa, S. Jiang, S. K. Mutha, X. Li, J. Baudry, and R. I. Tapping. 2010. Human TLRs 10 and 1 share common mechanisms of innate immune sensing but not signaling. J. Immunol. 184: 5094-5103.
55. Jancarik, J., R. Pufan, C. Hong, S. H. Kim, and R. Kim. 2004. Optimum solubility (OS) screening: An efficient method to optimize buffer conditions for homogeneity and crystallization of proteins. Acta Crystallogr. D Biol. Crystallogr. 60: 1670-1673. (Pubitemid 41103553)
56. McPherson, A. 1990. Current approaches to macromolecular crystallization. Eur. J. Biochem. 189: 1-23. (Pubitemid 20140947)
57. Jancarik, J., and S.-H. Kim. 1991. Sparse matrix sampling: A screening method for crystallization of proteins. J. Appl. Crystallogr. 24: 409-411. (Pubitemid 21679358)
58. McPherson, A. 1985. Use of polyethylene glycol in the crystallization of macromolecules. Methods Enzymol. 114: 120-125.
59. Sauter, C., J. D. Ng, B. Lorber, G. Keith, P. Brion, M. W. Hosseini, J.-M. Lehn, and R. Giege. 1999. Effects of additives for the crystallization of proteins and nucleic acids. J. Cryst. Growth 196: 365-376.
60. McPherson, A., S. Koszelak, H. Axelrod, J. Day, L. Robinson, M. McGrath, R. Williams, and D. Cascio. 1986. The effects of netural detergents on the crystallization of soluble proteins. J. Cryst. Growth 76: 547-553.
61. Garman, E. 2003. 'Cool' crystals: Macromolecular cryocrystallography and radiation damage. Curr. Opin. Struct. Biol. 13: 545-551. (Pubitemid 37244109)
62. Heras, B., and J. L. Martin. 2005. Post-crystallization treatments for improving diffraction quality of protein crystals. Acta Crystallogr. D Biol. Crystallogr. 61: 1173-1180. (Pubitemid 43961288)
63. Walter, T. S., C. Meier, R. Assenberg, K. F. Au, J. Ren, A. Verma, J. E. Nettleship, R. J. Owens, D. I. Stuart, and J. M. Grimes. 2006. Lysine methylation as a routine rescue strategy for protein crystallization. Structure 14: 1617-1622. (Pubitemid 46110803)
64. Neumeister, B., M. Faigle, M. Sommer, U. Zahringer, F. Stelter, R. Menzel, C. Schutt, and H. Northoff. 1998. Low endotoxic potential of Legionella pneumophila lipopolysaccharide due to failure of interaction with the monocyte lipopolysaccharide receptor CD14. Infect. Immun. 66: 4151-4157. (Pubitemid 28402685)
65. Juan, T. S., M. J. Kelley, D. A. Johnson, L. A. Busse, E. Hailman, S. D. Wright, and H. S. Lichenstein. 1995. Soluble CD14 truncated at amino acid 152 binds lipopolysaccharide (LPS) and enables cellular response to LPS. J. Biol. Chem. 270: 1382-1387.
66. Viriyakosol, S., and T. N. Kirkland. 1996. The N-terminal half of membrane CD14 is a functional cellular lipopolysaccharide receptor. Infect. Immun. 64: 653-656. (Pubitemid 26032843)
67. Alexander, S., and J. H. Elder. 1989. Endoglycosidases from Flavobacterium meningosepticum application to biological problems. Methods Enzymol. 179: 505-518. (Pubitemid 20044424)
68. Goyert, S. M., E. M. Ferrero, S. V. Seremetis, R. J. Winchester, J. Silver, and A. C. Mattison. 1986. Biochemistry and expression of myelomonocytic antigens. J. Immunol. 137: 3909-3914. (Pubitemid 17215321)
69. Ferrero, E., and S. M. Goyert. 1988. Nucleotide sequence of the gene encoding the monocyte differentiation antigen, CD14. Nucleic Acids Res. 16: 4173.
70. Enkhbayar, P., M. Kamiya, M. Osaki, T. Matsumoto, and N. Matsushima. 2004. Structural principles of leucine-rich repeat (LRR) proteins. Proteins 54: 394-403. (Pubitemid 38197354)
71. Creighton, T. E. 1987. Protein structure. Stability of alpha-helices. Nature 326: 547-548.
72. Barlow, D. J., and J. M. Thornton. 1988. Helix geometry in proteins. J. Mol. Biol. 201: 601-619.
73. Roberts, E., J. Eargle, D. Wright, and Z. Luthey-Schulten. 2006. MultiSeq: Unifying sequence and structure data for evolutionary analysis. BMC Bioinformatics 7: 382.
74. Inohara, N., and G. Nunez. 2002. ML-a conserved domain involved in innate immunity and lipid metabolism. Trends Biochem. Sci. 27: 219-221. (Pubitemid 34655436)
75. Ohto, U., K. Fukase, K. Miyake, and Y. Satow. 2007. Crystal structures of human MD-2 and its complex with antiendotoxic lipid IVa. Science 316: 1632-1634. (Pubitemid 46982039)
76. Ohto, U., K. Fukase, K. Miyake, and T. Shimizu. 2012. Structural basis of species-specific endotoxin sensing by innate immune receptor TLR4/MD-2. Proc. Natl. Acad. Sci. USA 109: 7421-7426.
77. Park, B. S., D. H. Song, H. M. Kim, B. S. Choi, H. Lee, and J. O. Lee. 2009. The structural basis of lipopolysaccharide recognition by the TLR4-MD-2 complex. Nature 458: 1191-1195.
78. Akashi, S., Y. Nagai, H. Ogata, M. Oikawa, K. Fukase, S. Kusumoto, K. Kawasaki, M. Nishijima, S. Hayashi, M. Kimoto, and K. Miyake. 2001. Human MD-2 confers on mouse Toll-like receptor 4 species-specific lipopolysaccharide recognition. Int. Immunol. 13: 1595-1599. (Pubitemid 33133886)
79. Gioannini, T. L., A. Teghanemt, D. Zhang, P. Prohinar, E. N. Levis R. S. Munford, and J. P. Weiss. 2007. Endotoxin-binding proteins modulate the susceptibility of bacterial endotoxin to deacylation by acyloxyacyl hydrolase. J. Biol. Chem. 282: 7877-7884. (Pubitemid 47093588)
80. McGinley, M. D., L. O. Narhi, M. J. Kelley, E. Davy, J. Robinson, M. F. Rohde, S. D. Wright, and H. S. Lichenstein. 1995. CD14: Physical properties and identification of an exposed site that is protected by lipopolysaccharide. J. Biol. Chem. 270: 5213-5218.
81. Juan, T. S., E. Hailman, M. J. Kelley, S. D. Wright, and H. S. Lichenstein. 1995. Identification of a domain in soluble CD14 essential for lipopolysaccharide (LPS) signaling but not LPS binding. J. Biol. Chem. 270: 17237-17242.
82. Viriyakosol, S., and T. N. Kirkland. 1995. A region of human CD14 required for lipopolysaccharide binding. J. Biol. Chem. 270: 361-368.
83. Viriyakosol, S., J. C. Mathison, P. S. Tobias, and T. N. Kirkland. 2000. Structurefunction analysis of CD14 as a soluble receptor for lipopolysaccharide. J. Biol. Chem. 275: 3144-3149. (Pubitemid 30083012)
84. Juan, T. S., E. Hailman, M. J. Kelley, L. A. Busse, E. Davy, C. J. Empig, L. O. Narhi, S. D. Wright, and H. S. Lichenstein. 1995. Identification of a lipopolysaccharide binding domain in CD14 between amino acids 57 and 64. J. Biol. Chem. 270: 5219-5224.
85. Shapiro, R. A., M. D. Cunningham, K. Ratcliffe, C. Seachord, J. Blake, J. Bajorath, A. Aruffo, and R. P. Darveau. 1997. Identification of CD14 residues involved in specific lipopolysaccharide recognition. Infect. Immun. 65: 293-297. (Pubitemid 27008936)
86. Takeuchi, O., T. Kawai, P. F. Muhlradt, M. Morr, J. D. Radolf, A. Zychlinsky, K. Takeda, and S. Akira. 2001. Discrimination of bacterial lipoproteins by Tolllike receptor 6. Int. Immunol. 13: 933-940. (Pubitemid 32685205)
87. Golenbock, D. T., R. Y. Hampton, N. Qureshi, K. Takayama, and C. R. Raetz. 1991. Lipid A-like molecules that antagonize the effects of endotoxins on human monocytes. J. Biol. Chem. 266: 19490-19498. (Pubitemid 21908258)
88. Muroi, M., and K. Tanamoto. 2006. Structural regions of MD-2 that determine the agonist-antagonist activity of lipid IVa. J. Biol. Chem. 281: 5484-5491. (Pubitemid 43847643)
89. Rietschel, E. T., T. Kirikae, F. U. Schade, U. Mamat, G. Schmidt, H. Loppnow, A. J. Ulmer, U. Zahringer, U. Seydel, F. Di Padova, et al. 1994. Bacterial endotoxin: Molecular relationships of structure to activity and function. FASEB J. 8: 217-225. (Pubitemid 24067145)
90. Mata-Haro, V., C. Cekic, M. Martin, P. M. Chilton, C. R. Casella, and T. C. Mitchell. 2007. The vaccine adjuvant monophosphoryl lipid A as a TRIFbiased agonist of TLR4. Science 316: 1628-1632. (Pubitemid 46982038)
91. Kim, H. M., B. S. Park, J. I. Kim, S. E. Kim, J. Lee, S. C. Oh, P. Enkhbayar, N. Matsushima, H. Lee, O. J. Yoo, and J. O. Lee. 2007. Crystal structure of the TLR4-MD-2 complex with bound endotoxin antagonist Eritoran. Cell 130: 906-917. (Pubitemid 47332573)
92. Hawkins, L. D., W. J. Christ, and D. P. Rossignol. 2004. Inhibition of endotoxin response by synthetic TLR4 antagonists. Curr. Top. Med. Chem. 4: 1147-1171. (Pubitemid 38923439)
93. Piazza, M., C. Rossini, S. Della Fiorentina, C. Pozzi, F. Comelli, I. Bettoni, P. Fusi, B. Costa, and F. Peri. 2009. Glycolipids and benzylammonium lipids as novel antisepsis agents: Synthesis and biological characterization. J. Med. Chem. 52: 1209-1213.
94. Piazza, M., L. Yu, A. Teghanemt, T. Gioannini, J. Weiss, and F. Peri. 2009. Evidence of a specific interaction between new synthetic antisepsis agents and CD14. Biochemistry 48: 12337-12344.
95. Piazza, M., V. Calabrese, G. Damore, R. Cighetti, T. Gioannini, J. Weiss, and F. Peri. 2012. A synthetic lipid A mimetic modulates human TLR4 activity. ChemMedChem 7: 213-217.
96. Schromm, A. B., K. Brandenburg, H. Loppnow, A. P. Moran, M. H. Koch, E. T. Rietschel, and U. Seydel. 2000. Biological activities of lipopolysaccharides are determined by the shape of their lipid A portion. Eur. J. Biochem. 267: 2008-2013. (Pubitemid 30185287)